UB Paderborn / Katalog / Suche / in CDI

The manufacturing considerations of bispecific antibodies

Expert opinion on biological therapy, 2022-08, Vol.22 (8), p.1043-1065

2022

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanism of phosphopeptide neoantigen immunogenicity

Nature communications, 2023-06, Vol.14 (1), p.3763-3763, Article 3763

2023

Link zum Volltext

Verfügbarkeit prüfen

TCR Fingerprinting and Off-Target Peptide Identification

Frontiers in immunology, 2019-10, Vol.10, p.2501-2501

2019

Link zum Volltext

Verfügbarkeit prüfen

Transcriptomic Maps of Colorectal Liver Metastasis: Machine Learning of Gene Activation Patterns and Epigenetic Trajectories in Support of Precision Medicine

Cancers, 2023-07, Vol.15 (15), p.3835

2023

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3819-3819

2018

Link zum Volltext

Verfügbarkeit prüfen

Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity

Nature communications, 2023-07, Vol.14 (1), p.4522-1

2023

Link zum Volltext

Verfügbarkeit prüfen

377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects

Journal for immunotherapy of cancer, 2020-11, Vol.8 (Suppl 3), p.A229-A230

2020

Link zum Volltext

Verfügbarkeit prüfen

Discovery informatics: its evolving role in drug discovery

Drug Discovery Today, 2002-09, Vol.7 (18), p.957-966

2002

Link zum Volltext

Verfügbarkeit prüfen

Effects of Heterocyclic Aromatic Substituents on Binding Affinities at Two Distinct Sites of Somatostatin Receptors. Correlation with the Electrostatic Potential of the Substituents

Journal of medicinal chemistry, 2003-05, Vol.46 (10), p.1858-1869

2003

Link zum Volltext

Verfügbarkeit prüfen

Photochemically Enhanced Binding of Small Molecules to the Tumor Necrosis Factor Receptor-1 Inhibits the Binding of TNF-α

Proceedings of the National Academy of Sciences - PNAS, 2001-10, Vol.98 (21), p.11879-11884

2001

Link zum Volltext

Verfügbarkeit prüfen

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

Molecular endocrinology (Baltimore, Md.), 1998-01, Vol.12 (1), p.137-145

1998

Link zum Volltext

Verfügbarkeit prüfen

Synthesis and Biological Activities of Potent Peptidomimetics Selective for Somatostatin Receptor Subtype 2

Proceedings of the National Academy of Sciences - PNAS, 1998-09, Vol.95 (18), p.10836-10841

1998

Link zum Volltext

Verfügbarkeit prüfen

AGEN2373 is a conditionally-active agonist antibody targeting the costimulatory receptor CD137 for the treatment of human malignancies

Journal of clinical oncology, 2019-05, Vol.37 (15_suppl), p.e14005-e14005

2019

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3825: INCAGN02390, a novel antagonist antibody that targets the co-inhibitory receptor TIM-3

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.3825-3825

2018

Link zum Volltext

Verfügbarkeit prüfen

Synthesis of a Substance P Antagonist with a Somatostatin Scaffold: Factors Affecting Agonism/Antagonism at GPCRs and the Role of Pseudosymmetry

Journal of medicinal chemistry, 2000-10, Vol.43 (21), p.3827-3831

2000

Link zum Volltext

Verfügbarkeit prüfen

FLOG: A system to select ?quasi-flexible? ligands complementary to a receptor of known three-dimensional structure

Journal of computer-aided molecular design, 1994-04, Vol.8 (2), p.153-174

1994

Link zum Volltext

Verfügbarkeit prüfen

Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients

Cancer immunology research, 2021-11, Vol.9 (11), p.1327-1341

2021

Link zum Volltext

Verfügbarkeit prüfen

Abstract 3643: INCAGN1876, a unique GITR agonist antibody that facilitates GITR oligomerization

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.3643-3643

2017

Link zum Volltext

Verfügbarkeit prüfen

Abstract 4609: Agenus’ next generation cancer vaccine platforms

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4609-4609

2017

Link zum Volltext

Verfügbarkeit prüfen

Structure and Function of G Protein-Coupled Receptors

Annual review of biochemistry, 1994, Vol.63 (1), p.101-132

1994

Link zum Volltext

Verfügbarkeit prüfen

Triangular platinum and nickel clusters: the "tinker-toy" construction of chains with high nuclearity

Journal of the American Chemical Society, 1985-10, Vol.107 (21), p.5968-5980

1985

Link zum Volltext

Verfügbarkeit prüfen

Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide Analogs (∗)

The Journal of biological chemistry, 1995-07, Vol.270 (27), p.15966-15969

1995

Link zum Volltext

Verfügbarkeit prüfen

Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amides

Journal of medicinal chemistry, 1990-09, Vol.33 (9), p.2522-2528

1990

Link zum Volltext

Verfügbarkeit prüfen

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

Molecular endocrinology (Baltimore, Md.), 1997-01, Vol.12 (1), p.137-145

Feighner, S. D.

1997

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

The manufacturing considerations of bispecific antibodies

Molecular mechanism of phosphopeptide neoantigen immunogenicity

TCR Fingerprinting and Off-Target Peptide Identification

Transcriptomic Maps of Colorectal Liver Metastasis: Machine Learning of Gene Activation Patterns and Epigenetic Trajectories in Support of Precision Medicine

Toxicological and pharmacological assessment of AGEN1884, a novel human IgG1 anti-CTLA-4 antibody

Abstract 3819: INCAGN02385 is an antagonist antibody targeting the co-inhibitory receptor LAG-3 for the treatment of human malignancies

Author Correction: Molecular mechanism of phosphopeptide neoantigen immunogenicity

377 AGEN2373 is a CD137 agonist antibody designed to leverage optimal CD137 and FcγR co-targeting to promote antitumor immunologic effects

Discovery informatics: its evolving role in drug discovery

Effects of Heterocyclic Aromatic Substituents on Binding Affinities at Two Distinct Sites of Somatostatin Receptors. Correlation with the Electrostatic Potential of the Substituents

Photochemically Enhanced Binding of Small Molecules to the Tumor Necrosis Factor Receptor-1 Inhibits the Binding of TNF-α

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

Synthesis and Biological Activities of Potent Peptidomimetics Selective for Somatostatin Receptor Subtype 2

AGEN2373 is a conditionally-active agonist antibody targeting the costimulatory receptor CD137 for the treatment of human malignancies

Abstract 3825: INCAGN02390, a novel antagonist antibody that targets the co-inhibitory receptor TIM-3

Synthesis of a Substance P Antagonist with a Somatostatin Scaffold: Factors Affecting Agonism/Antagonism at GPCRs and the Role of Pseudosymmetry

FLOG: A system to select ?quasi-flexible? ligands complementary to a receptor of known three-dimensional structure

Characteristics of Immune Memory and Effector Activity to Cancer-Expressed MHC Class I Phosphopeptides Differ in Healthy Donors and Ovarian Cancer Patients

Abstract 3643: INCAGN1876, a unique GITR agonist antibody that facilitates GITR oligomerization

Abstract 4609: Agenus’ next generation cancer vaccine platforms

Structure and Function of G Protein-Coupled Receptors

Triangular platinum and nickel clusters: the "tinker-toy" construction of chains with high nuclearity

Arginine 206 of the C5a Receptor Is Critical for Ligand Recognition and Receptor Activation by C-terminal Hexapeptide Analogs (∗)

Inhibition of human leukocyte elastase. 2. Inhibition by substituted cephalosporin esters and amides

Structural Requirements for the Activation of the Human Growth Hormone Secretagogue Receptor by Peptide and Nonpeptide Secretagogues

Suchergebnisse filtern